Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» olezarsen
olezarsen
ACC: Ionis' rare metabolic disorder drug slides from 100% efficacy, but FDA ambitions unchanged
Fierce Biotech
Mon, 04/8/24 - 10:50 am
Ionis Pharmaceuticals
clinical trials
olezarsen
familial chylomicronemia syndrome
Ionis Notches Phase III Win in Rare Genetic Disease, Plans to Submit NDA
BioSpace
Tue, 09/26/23 - 09:54 pm
Ionis Pharmaceuticals
antisense
olezarsen
Ionis' lipid-lowering drug hits phase 3 goal, raising hopes in untapped rare disease market
Fierce Biotech
Tue, 09/26/23 - 11:37 am
Ionis Pharmaceuticals
clinical trials
olezarsen
familial chylomicronemia syndrome